Related Experiment Video
Updated: Jun 5, 2025

11:35
Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
12.5K
Developing a RecT-assisted endogenous CRISPR/SzCas9 system for precise genome editing in Streptococcus zooepidemicus
Xuejing Zhang1, Feiyu Wang1, Xueping Guo2
1State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, People's Republic of China.
International Journal of Biological Macromolecules
|December 14, 2024
Summary
Researchers developed a new CRISPR gene editing system for Streptococcus zooepidemicus, improving hyaluronic acid production. This system enables precise genetic modifications, leading to enhanced yields and safer products for industrial applications.
Area of Science:
- Microbiology
- Biotechnology
- Genetic Engineering
Background:
- Streptococcus zooepidemicus is key for industrial hyaluronic acid (HA) production.
- Limited genetic tools hinder S. zooepidemicus strain improvement for HA manufacturing.
Purpose of the Study:
- To develop an efficient, markerless gene editing system for industrial S. zooepidemicus strains.
- To engineer S. zooepidemicus for enhanced hyaluronic acid production and improved safety profiles.
Main Methods:
- Developed a RecT-assisted endogenous CRISPR/SzCas9 system for S. zooepidemicus.
- Performed markerless gene deletion (hylb), gene substitution (VHb), and stop codon insertion (sagA).
- Iterative editing was employed to achieve desired genetic modifications.
Main Results:
- Successfully engineered a non-hemolytic S. zooepidemicus strain (SD-3) with reduced toxicity.
- Achieved a 39.7% increase in hyaluronic acid production, reaching 10.8 g/L.
- Produced high molecular weight hyaluronic acid (up to 2.8 x 10^6 Da) with uniform characteristics.
Conclusions:
- The novel CRISPR/SzCas9 system provides efficient genetic manipulation for S. zooepidemicus.
- Engineered strain SD-3 demonstrates significant potential for industrial hyaluronic acid production with enhanced yield and safety.
Related Concept Videos
CRISPR
49.3K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.3K
Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K
CRISPR and crRNAs
16.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.7K

